Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Identification of natural compounds with antiviral activities against SARS-associated coronavirus.

Identifieur interne : 000F38 ( Ncbi/Curation ); précédent : 000F37; suivant : 000F39

Identification of natural compounds with antiviral activities against SARS-associated coronavirus.

Auteurs : Shi-You Li [République populaire de Chine] ; Cong Chen ; Hai-Qing Zhang ; Hai-Yan Guo ; Hui Wang ; Lin Wang ; Xiang Zhang ; Shi-Neng Hua ; Jun Yu ; Pei-Gen Xiao ; Rong-Song Li ; Xuehai Tan

Source :

RBID : pubmed:15885816

Descripteurs français

English descriptors

Abstract

More than 200 Chinese medicinal herb extracts were screened for antiviral activities against Severe Acute Respiratory Syndrome-associated coronavirus (SARS-CoV) using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS) assay for virus-induced cytopathic effect (CPE). Four of these extracts showed moderate to potent antiviral activities against SARS-CoV with 50% effective concentration (EC50) ranging from 2.4 +/- 0.2 to 88.2 +/- 7.7 microg/ml. Out of the four, Lycoris radiata was most potent. To identify the active component, L. radiata extract was subjected to further fractionation, purification, and CPE/MTS assays. This process led to the identification of a single substance lycorine as an anti-SARS-CoV component with an EC50 value of 15.7 +/- 1.2 nM. This compound has a CC50 value of 14980.0 +/- 912.0 nM in cytotoxicity assay and a selective index (SI) greater than 900. The results suggested that four herbal extracts and the compound lycorine are candidates for the development of new anti-SARS-CoV drugs in the treatment of SARS.

DOI: 10.1016/j.antiviral.2005.02.007
PubMed: 15885816

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:15885816

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Identification of natural compounds with antiviral activities against SARS-associated coronavirus.</title>
<author>
<name sortKey="Li, Shi You" sort="Li, Shi You" uniqKey="Li S" first="Shi-You" last="Li">Shi-You Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Beijing Genomics Institute, Chinese Academy of Sciences, Beijing 101300, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Beijing Genomics Institute, Chinese Academy of Sciences, Beijing 101300</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chen, Cong" sort="Chen, Cong" uniqKey="Chen C" first="Cong" last="Chen">Cong Chen</name>
</author>
<author>
<name sortKey="Zhang, Hai Qing" sort="Zhang, Hai Qing" uniqKey="Zhang H" first="Hai-Qing" last="Zhang">Hai-Qing Zhang</name>
</author>
<author>
<name sortKey="Guo, Hai Yan" sort="Guo, Hai Yan" uniqKey="Guo H" first="Hai-Yan" last="Guo">Hai-Yan Guo</name>
</author>
<author>
<name sortKey="Wang, Hui" sort="Wang, Hui" uniqKey="Wang H" first="Hui" last="Wang">Hui Wang</name>
</author>
<author>
<name sortKey="Wang, Lin" sort="Wang, Lin" uniqKey="Wang L" first="Lin" last="Wang">Lin Wang</name>
</author>
<author>
<name sortKey="Zhang, Xiang" sort="Zhang, Xiang" uniqKey="Zhang X" first="Xiang" last="Zhang">Xiang Zhang</name>
</author>
<author>
<name sortKey="Hua, Shi Neng" sort="Hua, Shi Neng" uniqKey="Hua S" first="Shi-Neng" last="Hua">Shi-Neng Hua</name>
</author>
<author>
<name sortKey="Yu, Jun" sort="Yu, Jun" uniqKey="Yu J" first="Jun" last="Yu">Jun Yu</name>
</author>
<author>
<name sortKey="Xiao, Pei Gen" sort="Xiao, Pei Gen" uniqKey="Xiao P" first="Pei-Gen" last="Xiao">Pei-Gen Xiao</name>
</author>
<author>
<name sortKey="Li, Rong Song" sort="Li, Rong Song" uniqKey="Li R" first="Rong-Song" last="Li">Rong-Song Li</name>
</author>
<author>
<name sortKey="Tan, Xuehai" sort="Tan, Xuehai" uniqKey="Tan X" first="Xuehai" last="Tan">Xuehai Tan</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15885816</idno>
<idno type="pmid">15885816</idno>
<idno type="doi">10.1016/j.antiviral.2005.02.007</idno>
<idno type="wicri:Area/PubMed/Corpus">002749</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002749</idno>
<idno type="wicri:Area/PubMed/Curation">002749</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002749</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002675</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002675</idno>
<idno type="wicri:Area/Ncbi/Merge">000F38</idno>
<idno type="wicri:Area/Ncbi/Curation">000F38</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Identification of natural compounds with antiviral activities against SARS-associated coronavirus.</title>
<author>
<name sortKey="Li, Shi You" sort="Li, Shi You" uniqKey="Li S" first="Shi-You" last="Li">Shi-You Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Beijing Genomics Institute, Chinese Academy of Sciences, Beijing 101300, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Beijing Genomics Institute, Chinese Academy of Sciences, Beijing 101300</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chen, Cong" sort="Chen, Cong" uniqKey="Chen C" first="Cong" last="Chen">Cong Chen</name>
</author>
<author>
<name sortKey="Zhang, Hai Qing" sort="Zhang, Hai Qing" uniqKey="Zhang H" first="Hai-Qing" last="Zhang">Hai-Qing Zhang</name>
</author>
<author>
<name sortKey="Guo, Hai Yan" sort="Guo, Hai Yan" uniqKey="Guo H" first="Hai-Yan" last="Guo">Hai-Yan Guo</name>
</author>
<author>
<name sortKey="Wang, Hui" sort="Wang, Hui" uniqKey="Wang H" first="Hui" last="Wang">Hui Wang</name>
</author>
<author>
<name sortKey="Wang, Lin" sort="Wang, Lin" uniqKey="Wang L" first="Lin" last="Wang">Lin Wang</name>
</author>
<author>
<name sortKey="Zhang, Xiang" sort="Zhang, Xiang" uniqKey="Zhang X" first="Xiang" last="Zhang">Xiang Zhang</name>
</author>
<author>
<name sortKey="Hua, Shi Neng" sort="Hua, Shi Neng" uniqKey="Hua S" first="Shi-Neng" last="Hua">Shi-Neng Hua</name>
</author>
<author>
<name sortKey="Yu, Jun" sort="Yu, Jun" uniqKey="Yu J" first="Jun" last="Yu">Jun Yu</name>
</author>
<author>
<name sortKey="Xiao, Pei Gen" sort="Xiao, Pei Gen" uniqKey="Xiao P" first="Pei-Gen" last="Xiao">Pei-Gen Xiao</name>
</author>
<author>
<name sortKey="Li, Rong Song" sort="Li, Rong Song" uniqKey="Li R" first="Rong-Song" last="Li">Rong-Song Li</name>
</author>
<author>
<name sortKey="Tan, Xuehai" sort="Tan, Xuehai" uniqKey="Tan X" first="Xuehai" last="Tan">Xuehai Tan</name>
</author>
</analytic>
<series>
<title level="j">Antiviral research</title>
<idno type="ISSN">0166-3542</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amaryllidaceae Alkaloids (chemistry)</term>
<term>Amaryllidaceae Alkaloids (pharmacology)</term>
<term>Animals</term>
<term>Antiviral Agents (chemistry)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Cytopathogenic Effect, Viral</term>
<term>Drug Evaluation, Preclinical</term>
<term>Drugs, Chinese Herbal (chemistry)</term>
<term>Drugs, Chinese Herbal (pharmacology)</term>
<term>Humans</term>
<term>Liliaceae (chemistry)</term>
<term>Microbial Sensitivity Tests</term>
<term>Phenanthridines (chemistry)</term>
<term>Phenanthridines (pharmacology)</term>
<term>Phytotherapy</term>
<term>SARS Virus (drug effects)</term>
<term>Tetrazolium Salts</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Alcaloïdes des Amaryllidaceae ()</term>
<term>Alcaloïdes des Amaryllidaceae (pharmacologie)</term>
<term>Animaux</term>
<term>Antiviraux ()</term>
<term>Antiviraux (pharmacologie)</term>
<term>Cellules Vero</term>
<term>Effet cytopathogène viral</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Liliaceae ()</term>
<term>Médicaments issus de plantes chinoises ()</term>
<term>Médicaments issus de plantes chinoises (pharmacologie)</term>
<term>Phytothérapie</term>
<term>Phénanthridines ()</term>
<term>Phénanthridines (pharmacologie)</term>
<term>Sels de tétrazolium</term>
<term>Tests de sensibilité microbienne</term>
<term>Virus du SRAS ()</term>
<term>Évaluation préclinique de médicament</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Amaryllidaceae Alkaloids</term>
<term>Antiviral Agents</term>
<term>Drugs, Chinese Herbal</term>
<term>Phenanthridines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Amaryllidaceae Alkaloids</term>
<term>Antiviral Agents</term>
<term>Drugs, Chinese Herbal</term>
<term>Phenanthridines</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Liliaceae</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Alcaloïdes des Amaryllidaceae</term>
<term>Antiviraux</term>
<term>Médicaments issus de plantes chinoises</term>
<term>Phénanthridines</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Cytopathogenic Effect, Viral</term>
<term>Drug Evaluation, Preclinical</term>
<term>Humans</term>
<term>Microbial Sensitivity Tests</term>
<term>Phytotherapy</term>
<term>Tetrazolium Salts</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Alcaloïdes des Amaryllidaceae</term>
<term>Animaux</term>
<term>Antiviraux</term>
<term>Cellules Vero</term>
<term>Effet cytopathogène viral</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Liliaceae</term>
<term>Médicaments issus de plantes chinoises</term>
<term>Phytothérapie</term>
<term>Phénanthridines</term>
<term>Sels de tétrazolium</term>
<term>Tests de sensibilité microbienne</term>
<term>Virus du SRAS</term>
<term>Évaluation préclinique de médicament</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">More than 200 Chinese medicinal herb extracts were screened for antiviral activities against Severe Acute Respiratory Syndrome-associated coronavirus (SARS-CoV) using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS) assay for virus-induced cytopathic effect (CPE). Four of these extracts showed moderate to potent antiviral activities against SARS-CoV with 50% effective concentration (EC50) ranging from 2.4 +/- 0.2 to 88.2 +/- 7.7 microg/ml. Out of the four, Lycoris radiata was most potent. To identify the active component, L. radiata extract was subjected to further fractionation, purification, and CPE/MTS assays. This process led to the identification of a single substance lycorine as an anti-SARS-CoV component with an EC50 value of 15.7 +/- 1.2 nM. This compound has a CC50 value of 14980.0 +/- 912.0 nM in cytotoxicity assay and a selective index (SI) greater than 900. The results suggested that four herbal extracts and the compound lycorine are candidates for the development of new anti-SARS-CoV drugs in the treatment of SARS.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F38 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000F38 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:15885816
   |texte=   Identification of natural compounds with antiviral activities against SARS-associated coronavirus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:15885816" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021